ArticlePharmacology research & perspectives2018

Conflicting evidence for the role of JNK as a target in breast cancer cell proliferation: Comparisons between pharmacological inhibition and selective shRNA knockdown approaches.

Rachel A Wood et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.